Meet the OBR Editorial Board

Editor's Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards's insights will bring great value to the oncology community.

View all Editorial Board Member Commentary

Browse Editors by Section

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

Comments

Seattle Genetics Announces Positive Topline Results from Pivotal Trial of Tucatinib in Locally Advanced or Metastatic HER2-Positive Breast Cancer

quotesThis is a long-awaited landmark and registrational trial testing the HER2-specific kinase inhibitor …quotes

member-photo

Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Rutgers-CINJ Associate Director, Clinical Research
Director Clinical Oncology Research, RWJ-B Health System

Comments

First Opinion: PhRMA’s Talking Points Shouldn’t Derail The Pelosi Drug Pricing Bill

quotesKudos to Dr Peter Bach on responding to PhRMA talking points on drug pricing. I am all for R&D …quotes

member-photo

Ted Okon

Executive Director
Community Oncology Alliance

Comments

PBM Middlemen Continue to Dodge Responsibility for Patient Suffering and Rising Drug Prices

quotesPBMs are getting more brazen in how they delay and deny cancer patients their oral drugs. Anyone in …quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

Why The Cancer ‘Moonshot’ Has Been So Disappointing

quotesI am somewhat “dazed and confused” by the article entitled “Why the Cancer Moonshot Has Been S…quotes

member-photo

Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
Grover C. Bagby Chair of Prostate Cancer Research
OHSU Knight Cancer Institute Deputy Director, OHSU Knight Cancer Institute, School of Medicine
Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine

Comments

Myovant to Submit Lead Drug For Prostate Cancer Approval After Phase 3 Results

quotesAn oral option for primary hormonal therapy will be attractive for some patients, particularly those…quotes

member-photo

H. Jack West, MD

Associate Clinical Professor, Medical Oncology
Executive Director, Employer Services
City of Hope Comprehensive Cancer Center
Duarte, CA

Comments

Lilly Opens First Ever Randomized Phase 3 Clinical Trial in Treatment-Naïve RET Fusion-Positive Non-Small Cell Lung Cancer

quotesGiven the remarkable efficacy of selpercatinib, this is a trial that thoracic oncology experts debat…quotes

member-photo

Winston Wong, PharmD

President, W-Squared Group

Comments

Dana-Farber Cancer Institute Analyzes Clinical Pathway Use to Reduce Unwarranted Variation

quotesThis piece is a great example of a pathway program in process. Clinical pathways are not meant to b…quotes

member-photo

Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology
Department of Medicine,Cedars-Sinai Medical Center
Associate Director for Academic Program Development
Samuel Oschin Comprehensive Cancer Institute
Professor of Medicine and Urology, Emeritus
David Geffen School of Medicine at UCLA

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO
President, Minnesota Oncology

Comments

SABCS 2019 – AstraZeneca and Daiichi Join the Her2 Resistance

quotesExtremely impressive efficacy in heavily pretreated metastatic HER-2 + breast cancer but the presenc…quotes

member-photo

Jeff Patton, M.D.

CEO
Tennessee Oncology

Comments

First Opinion: Physicians Aren’t ‘Burning Out.’ They’re Suffering From Moral Injury

quotesI found this article both fascinating and enlightening. I had not thought of "burnout" in terms of …quotes

member-photo

Thomas Marsland, MD

Vice President
Integrated Community Oncology Network
Former Community Representative
ASCO Board of Directors

Comments

ASCO Launches New Payment Reform Model to Transform Cancer Care Delivery and Enhance the Quality of Patient Care

quotesSo a tale of two cities.....it is interesting to compare the oncology alternative payment model to t…quotes

member-photo

William Harwin MD

Florida Cancer Specialists
President and Managing Partner

Comments

Memorial Sloan Kettering to Offer DigniCap® Scalp Cooling Device in New York Metro Area Locations

quotesAt Florida Cancer Specialists we have been using DigniCap for several months at 3 of our site and it…quotes

member-photo

Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics

Professor and Chair, Department of Radiation Oncology

Interim Director, Samuel Oschin Comprehensive Cancer Institute

Cedars-Sinai Medical Center

Comments

F.D.A. Nominee Clears Senate Panel

quotesSteve Hahn is very well regarded in the ASTRO community. He's a radiation oncologist who is also boa…quotes